GENERIUM is a full-cycle innovative high-end pharmaceutical company. We are the leader in Russian orphan pharmaceutical market.
GENERIUM possesses its own R&D park, which is capable to handle the full cycle of development of any biological drug, from molecule design to commercial production. We are collaborating in science with leading biotechnological companies and institutes from all over the world.
784thin Eastern Europe